Vitamin D status and mortality of German hemodialysis patients

Anticancer Research

Volumn 32, Issue 1 PART 2, 2012, Pages 391-395

  Krause, Rolfdieter ^a,b   Schober Halstenberg, Hans Jürgen ^b   Edenharter, Günter ^c   Haas, Kirsten ^c   Roth, Heinz Jürgen ^d   Frei, Ulrich ^b  

^a KfH Nephrological Center Moabit   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Edenharter Research   (Germany)

^d MVZ Dr Limbach and Kollegen ^*  (Germany)

Author keywords

Calcidiol; Hemodialysis; Mortality; Retrospective analysis; Vitamin D

Indexed keywords

VITAMIN D;

ADULT; AGED; CANCER MORTALITY; COHORT ANALYSIS; COMPARATIVE STUDY; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GERMANY; HEART DISEASE; HEMODIALYSIS PATIENT; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VITAMIN D DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; CALCIFEDIOL; CARDIOVASCULAR DISEASES; COMMUNICABLE DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84856023399     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Heaney RP: The case for improving vitamin D status. J Steroid Biochem Mol Biol 103: 635-641, 2007.
2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 113: S1-S130 (see Chapter 3.1: Diagnosis of CKD-MBD: biochemical abnormalities, S22-S49), 2009.
3. Autier P and Gandini S: Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 167: 1730-1737, 2007. (Pubitemid 47403059)
4. Michos, ED and Melamed ML: Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 11: 7-12, 2008. (Pubitemid 350295219)
5. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Herman MA, Camargo CA Jr. and Thadhani R: Activated injectable Vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol 16: 1115-1125, 2005. (Pubitemid 41710323)
6. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M and Thadhani R: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72: 1004-1013, 2007. (Pubitemid 47530570)
7. Holick MF: Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19: 73-78, 2009.
8. Holick MF: Vitamin D deficiency. N Engl J Med 357: 266-281, 2007
9. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH and Weaver CM: Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 96: 1911-1930, 2011.
10. Rostand SG: Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30: 150-155, 1997.
11. Zittermann W, Schleithoff SS, Frisch S, Götting C, Kuhn J, Koertke H, Kleesiek K, Tenderich G and Koerfer R: Circulating calcitriol concentrations and total mortality. Clin Chem 55: 1163-1170, 2009.
12. Scragg R, Jackson R, Holdaway IM, Lim T and Beaglehole R: Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 19: 559-563, 1990. (Pubitemid 20331800)
13. U.S. Renal Data System. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 2009.
14. Ansell D, Roderick P, Hodsman A, Ford D, Steenkamp R and Tomson C: UK Renal Registry 11th Annual Report (December 2008): Chapter 7: Survival and causes of death of UK adult patients on renal replacement therapy in 2007: National and centre-specific analyses, UK Renal Registry, Bristol, 2008.
15. Frei U and Schober-Halstenberg HJ: Nierenersatztherapie in Deutschland 2006-2007 (Renal Replacement Therapy in Germany 2006-2007). QuaSi-Niere, Berlin, 2008.
16. 3. Semin Dial 20: 316-324, 2007.
17. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldi J, Boehm BO, Weihrauch G and Maerz W: Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168: 1340-1349, 2008. (Pubitemid 351930842)
18. Shoben AB, Rudser KD, de Boer IH, Young B and Kestenbaum B: Association of oral calcitriol with improved survival in nondialyzed CKD. JAm Soc Nephrol 19: 1613-1619, 2008.
19. Tuohimaa P: An optimal serum calcidiol concentration for cancer prevention. Anticancer Res 31: 1503-1504, 2011.
20. Liu PT, Stenger S, Li H and Modlin R: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773, 2006.
21. Zasloff, M: Fighting Infections with Vitamin D. Nat Med 12: 388-390, 2006.
22. Bothe V and Schmidt-Gayk H: Competitive protein-binding assay for the diagnosis of hyper- and hypovitaminosis. In: Calcium regulating Hormones, Vitamin D Metabolites, and Cyclic AMP. Schmidt-Gayk H, Armbruster FP and Bouillon R (eds.). Berlin, Springer pp. 258-279, 1990.
23. Roth HJ, Zahn I, Alkier R and Schmidt H: Validation of the first automated chemiluminescence protein-binding assay for the detection of 25-hydroxycalciferol. Clin Lab 47: 357-365, 2001. (Pubitemid 32685480)
24. Lips P: Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 89-90: 611-614, 2004.
25. Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu Y-W, Martins D, Adler SG and Norris KC: Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 76: 977-983, 2009.
26. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M and Vasan RS: Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503-511, 2008.
27. Liu PT, Stenger S, Tang DH and Modlin R: Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 179: 2060-2063, 2007.
28. Arends J: Vitamin D in oncology. Forsch Komplementmed 18(4): 176-184, 2011.
29. Bayer W: Vitamin D und Krebs. Dt Zeitschr Onkologie 41: 106-111, 2011.
30. Taneja S, Mandayam S, Kayani ZZ, Kuo YF and Shahinian VB: Comparison of stage at diagnosis of cancer in patients on dialysis versus the general population. Clin J Am Soc Nephrol 2(5): 1008-1013, 2007.
31. 3] and mortality in hemodialysis patients. MD thesis, Charité - University Medical Center, Berlin, 2010. (In German.) Download at: http://www.diss.fu- berlin.de/diss/receive/FUDISS-thesis-19570.
32. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK and Zager PG: Mortality risk among hemodialysis patients receiving different vitamin D analogues. Kidney Int 70: 1858-1865, 2006. (Pubitemid 44684819)